Your browser doesn't support javascript.
loading
Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
Chamberlain, James M; Kapur, Jaideep; Shinnar, Shlomo; Elm, Jordan; Holsti, Maija; Babcock, Lynn; Rogers, Alex; Barsan, William; Cloyd, James; Lowenstein, Daniel; Bleck, Thomas P; Conwit, Robin; Meinzer, Caitlyn; Cock, Hannah; Fountain, Nathan B; Underwood, Ellen; Connor, Jason T; Silbergleit, Robert.
Afiliación
  • Chamberlain JM; Division of Emergency Medicine Children's National Hospital, Washington, DC, USA.
  • Kapur J; Department of Neurology, University of Virginia Health Sciences Center, Charlottesville, VA, USA.
  • Shinnar S; Neurology, Pediatrics and Epidemiology and Population Health Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Elm J; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
  • Holsti M; Division of Pediatric Emergency Medicine, University of Utah, Salt Lake City, UT, USA.
  • Babcock L; Division of Pediatric Emergency Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.
  • Rogers A; Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, USA; Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
  • Barsan W; Department of Emergency Medicine, Neuro Emergencies Research, University of Michigan, Ann Arbor, MI, USA.
  • Cloyd J; Center for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.
  • Lowenstein D; Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
  • Bleck TP; Division of Stroke and Neurocritical Care, Northwestern University Feinberg School of Medicine, Chicago, IL USA.
  • Conwit R; National Institute of Neurological Disorders and Stroke, National Institutes of Health Neuroscience Center, Bethesda, MD, USA.
  • Meinzer C; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
  • Cock H; Institute of Molecular and Clinical Sciences, St George's University of London, London, UK.
  • Fountain NB; Department of Neurology, University of Virginia Health Sciences Center, Charlottesville, VA, USA.
  • Underwood E; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
  • Connor JT; ConfluenceStat LLC and University of Central Florida College of Medicine, Cooper City, FL, USA.
  • Silbergleit R; Department of Emergency Medicine, Neuro Emergencies Research, University of Michigan, Ann Arbor, MI, USA. Electronic address: robert.silbergleit@umich.edu.
Lancet ; 395(10231): 1217-1224, 2020 04 11.
Article en En | MEDLINE | ID: mdl-32203691
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fenitoína / Estado Epiléptico / Ácido Valproico / Levetiracetam / Anticonvulsivantes Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fenitoína / Estado Epiléptico / Ácido Valproico / Levetiracetam / Anticonvulsivantes Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Año: 2020 Tipo del documento: Article